Correlation Between Gain Therapeutics and NewAmsterdam Pharma
Can any of the company-specific risk be diversified away by investing in both Gain Therapeutics and NewAmsterdam Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gain Therapeutics and NewAmsterdam Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gain Therapeutics and NewAmsterdam Pharma, you can compare the effects of market volatilities on Gain Therapeutics and NewAmsterdam Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gain Therapeutics with a short position of NewAmsterdam Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gain Therapeutics and NewAmsterdam Pharma.
Diversification Opportunities for Gain Therapeutics and NewAmsterdam Pharma
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Gain and NewAmsterdam is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Gain Therapeutics and NewAmsterdam Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NewAmsterdam Pharma and Gain Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gain Therapeutics are associated (or correlated) with NewAmsterdam Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NewAmsterdam Pharma has no effect on the direction of Gain Therapeutics i.e., Gain Therapeutics and NewAmsterdam Pharma go up and down completely randomly.
Pair Corralation between Gain Therapeutics and NewAmsterdam Pharma
Given the investment horizon of 90 days Gain Therapeutics is expected to under-perform the NewAmsterdam Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Gain Therapeutics is 1.81 times less risky than NewAmsterdam Pharma. The stock trades about -0.21 of its potential returns per unit of risk. The NewAmsterdam Pharma is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 870.00 in NewAmsterdam Pharma on September 1, 2024 and sell it today you would earn a total of 36.00 from holding NewAmsterdam Pharma or generate 4.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Gain Therapeutics vs. NewAmsterdam Pharma
Performance |
| Timeline |
| Gain Therapeutics |
| NewAmsterdam Pharma |
Gain Therapeutics and NewAmsterdam Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Gain Therapeutics and NewAmsterdam Pharma
The main advantage of trading using opposite Gain Therapeutics and NewAmsterdam Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gain Therapeutics position performs unexpectedly, NewAmsterdam Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NewAmsterdam Pharma will offset losses from the drop in NewAmsterdam Pharma's long position.| Gain Therapeutics vs. Tff Pharmaceuticals | Gain Therapeutics vs. Eliem Therapeutics | Gain Therapeutics vs. Inhibrx | Gain Therapeutics vs. Enliven Therapeutics |
| NewAmsterdam Pharma vs. NewAmsterdam Pharma | NewAmsterdam Pharma vs. Scilex Holding | NewAmsterdam Pharma vs. OmniAb Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |